16-Hour Fasting Plus Serplulimab and CAPEOX as Neoadjuvant Therapy in pMMR/MSS Advanced Mid-to-Low Rectal Cancer

Clinical trial NCT07779694 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07779694
Sponsor: Zhejiang University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

pMMR/MSS Locally Advanced Rectal Carcinoma Fasting, Intermittent

Start date: 2026-09-01
Primary completion: 2028-12-31
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.